CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 47.06%

Compliant submissions 8

Incompliant submissions 9

Total trials 17

My Organizations' Clinical Trials

Showing 300 of 867 entries

View as:

Hidradenitis - an Analysis of Genetic Traits and Linkages in Families

Phase: N/A Priority: Normal

NCT ID: NCT05710393 Org: User:

Start: 09/17/19 End: 12/01/27 Due: 12/01/28

The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial

Phase: N/A Priority: Normal

NCT ID: NCT06871111 Org: User:

Start: 08/01/25 End: 02/01/28 Due: 02/01/29

FITting Non-invasive Tests in Lynch Syndrome Surveillance

Phase: N/A Priority: Normal

NCT ID: NCT06898996 Org: User:

Start: 09/01/25 End: 04/01/35 Due: 04/01/36

Patient Acuity Rating: a Tool to Prevent In-Hospital Cardiac Arrest

Phase: N/A Priority: Normal

NCT ID: NCT01082991 Org: User:

Start: 10/31/09 End: 12/31/13 Due: 12/31/14

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00515112 Org: User:

Start: 07/31/07 End: 08/31/12 Due: 08/31/13

Changes in Nasal Patency With Changes in Posture, Temperature, Humidity and Nasal Patency Seen by Acoustic Rhinometry

Phase: N/A Priority: Normal

NCT ID: NCT00147888 Org: User:

Start: 03/31/04 End: 12/31/06 Due: 12/31/07

Nitrous Oxide as Treatment for Fibromyalgia

Phase: N/A Priority: Normal

NCT ID: NCT05357066 Org: User:

Start: 11/12/21 End: 12/01/26 Due: 12/01/27

Individual Differences in Diabetes Risk: Role of Slow WaveSleep

Phase: N/A Priority: Normal

NCT ID: NCT00989378 Org: User:

Start: 11/30/08 End: 09/30/10 Due: 09/30/11

Comparison of Two Methods of Negative Pressure Wound Therapy

Phase: N/A Priority: Normal

NCT ID: NCT00724750 Org: User:

Start: 07/31/06 End: 05/31/08 Due: 05/31/09

Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women

Phase: N/A Priority: Normal

NCT ID: NCT05534932 Org: User:

Start: 10/27/22 End: 12/31/25 Due: 12/31/26

Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase: N/A Priority: Normal

NCT ID: NCT00015977 Org: User:

Start: 11/30/01 End: 01/31/05 Due: 01/31/06

A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms

Phase: N/A Priority: Normal

NCT ID: NCT04955938 Org: User:

Start: 10/29/21 End: 06/07/23 Due: 06/07/24

Effectiveness of Chest Compressions Under Mild Hypoxia

Phase: N/A Priority: Normal

NCT ID: NCT04072484 Org: User:

Start: 08/16/19 End: 10/01/20 Due: 10/01/21

Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02046421 Org: User:

Start: 11/30/13 End: 05/31/18 Due: 05/31/19

TMP-Visitas al Hogar

Phase: N/A Priority: Normal

NCT ID: NCT03076268 Org: User:

Start: 03/02/17 End: 08/29/19 Due: 08/29/20

CKD Report Card Pilot Trial

Phase: N/A Priority: Normal

NCT ID: NCT04119570 Org: User:

Start: 05/15/18 End: 09/15/18 Due: 09/15/19

Correlation of Nasal Volume, Cross-Sectional Area With Nasalance Scores Measured by Acoustic Rhinometry and Nasometry

Phase: N/A Priority: Normal

NCT ID: NCT00147940 Org: User:

Start: 04/30/04 End: 08/31/05 Due: 08/31/06

A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

Phase: N/A Priority: Normal

NCT ID: NCT01258634 Org: User:

Start: 07/31/10 End: 11/30/11 Due: 11/30/12

Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT00343850 Org: User:

Start: 09/30/06 End: 03/31/07 Due: 03/31/08

Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies

Phase: N/A Priority: Normal

NCT ID: NCT02985554 Org: User:

Start: 03/20/17 End: 06/22/20 Due: 06/22/21

Communication Bridge Speech Therapy Research Study

Phase: N/A Priority: Normal

NCT ID: NCT02439853 Org: User:

Start: 03/31/13 End: 01/31/20 Due: 01/31/21

HealtheRx Survey for Pulmonary Research Registry Recruitment

Phase: N/A Priority: Normal

NCT ID: NCT02653066 Org: User:

Start: 12/31/15 End: 12/31/19 Due: 12/31/20

Inhaled Nitric Oxide and Neuroprotection in Premature Infants

Phase: N/A Priority: Normal

NCT ID: NCT00515281 Org: User:

Start: 05/31/08 End: 11/28/23 Due: 11/28/24

Oxalate and Citrate in Humans - Response to Citrate

Phase: N/A Priority: Normal

NCT ID: NCT06944223 Org: User:

Start: 05/05/25 End: 06/01/27 Due: 06/01/28

Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis

Phase: N/A Priority: Normal

NCT ID: NCT01071512 Org: User:

Start: 04/30/10 End: 01/31/16 Due: 01/31/17

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Hidradenitis - an Analysis of Genetic Traits and Linkages in Families	NCT05710393	University of Chicago	user2@example.com	None	2019-09-17	2027-12-01	2028-12-01	-	-	2025-07-14
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial	NCT06871111	University of Chicago	user2@example.com	None	2025-08-01	2028-02-01	2029-02-01	-	-	2025-07-14
FITting Non-invasive Tests in Lynch Syndrome Surveillance	NCT06898996	University of Chicago	user2@example.com	None	2025-09-01	2035-04-01	2036-04-01	-	-	2025-07-14
Patient Acuity Rating: a Tool to Prevent In-Hospital Cardiac Arrest	NCT01082991	University of Chicago	user2@example.com	None	2009-10-31	2013-12-31	2014-12-31	-	-	2025-07-14
Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer	NCT00515112	University of Chicago	user2@example.com	None	2007-07-31	2012-08-31	2013-08-31	-	-	2025-07-14
Changes in Nasal Patency With Changes in Posture, Temperature, Humidity and Nasal Patency Seen by Acoustic Rhinometry	NCT00147888	University of Chicago	user2@example.com	None	2004-03-31	2006-12-31	2007-12-31	-	-	2025-07-14
Nitrous Oxide as Treatment for Fibromyalgia	NCT05357066	University of Chicago	user2@example.com	None	2021-11-12	2026-12-01	2027-12-01	-	-	2025-07-14
Individual Differences in Diabetes Risk: Role of Slow WaveSleep	NCT00989378	University of Chicago	user2@example.com	None	2008-11-30	2010-09-30	2011-09-30	-	-	2025-07-14
Comparison of Two Methods of Negative Pressure Wound Therapy	NCT00724750	University of Chicago	user2@example.com	None	2006-07-31	2008-05-31	2009-05-31	-	-	2025-07-14
Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women	NCT05534932	University of Chicago	user2@example.com	None	2022-10-27	2025-12-31	2026-12-31	-	-	2025-07-14
Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy	NCT00015977	University of Chicago	user2@example.com	None	2001-11-30	2005-01-31	2006-01-31	-	-	2025-07-14
A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms	NCT04955938	University of Chicago	user2@example.com	None	2021-10-29	2023-06-07	2024-06-07	-	-	2025-07-14
Effectiveness of Chest Compressions Under Mild Hypoxia	NCT04072484	University of Chicago	user2@example.com	None	2019-08-16	2020-10-01	2021-10-01	-	-	2025-07-14
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	NCT02046421	University of Chicago	user2@example.com	None	2013-11-30	2018-05-31	2019-05-31	-	-	2025-07-14
TMP-Visitas al Hogar	NCT03076268	University of Chicago	user2@example.com	None	2017-03-02	2019-08-29	2020-08-29	-	-	2025-07-14
CKD Report Card Pilot Trial	NCT04119570	University of Chicago	user2@example.com	None	2018-05-15	2018-09-15	2019-09-15	-	-	2025-07-14
Correlation of Nasal Volume, Cross-Sectional Area With Nasalance Scores Measured by Acoustic Rhinometry and Nasometry	NCT00147940	University of Chicago	user2@example.com	None	2004-04-30	2005-08-31	2006-08-31	-	-	2025-07-14
A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response	NCT01258634	University of Chicago	user2@example.com	None	2010-07-31	2011-11-30	2012-11-30	-	-	2025-07-14
Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis	NCT00343850	University of Chicago	user2@example.com	None	2006-09-30	2007-03-31	2008-03-31	-	-	2025-07-14
Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies	NCT02985554	University of Chicago	user2@example.com	None	2017-03-20	2020-06-22	2021-06-22	-	-	2025-07-14
Communication Bridge Speech Therapy Research Study	NCT02439853	University of Chicago	user2@example.com	None	2013-03-31	2020-01-31	2021-01-31	-	-	2025-07-14
HealtheRx Survey for Pulmonary Research Registry Recruitment	NCT02653066	University of Chicago	user2@example.com	None	2015-12-31	2019-12-31	2020-12-31	-	-	2025-07-14
Inhaled Nitric Oxide and Neuroprotection in Premature Infants	NCT00515281	University of Chicago	user2@example.com	None	2008-05-31	2023-11-28	2024-11-28	-	-	2025-07-14
Oxalate and Citrate in Humans - Response to Citrate	NCT06944223	University of Chicago	user2@example.com	None	2025-05-05	2027-06-01	2028-06-01	-	-	2025-07-14
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis	NCT01071512	University of Chicago	user2@example.com	None	2010-04-30	2016-01-31	2017-01-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance